It was a pleasure connecting with so many urologists and professionals committed to advancing prostate cancer diagnosis.
A standout moment was the presentation “Artificial intelligence-assisted multiparametric ultrasound versus MRI to detect prostate cancer (PCaVision): a prospective, multicentre, paired, non-inferiority diagnostic study”, where D.L. van den Kroonenberg presented the results of the Dutch Head-to-Head (DH2H) clinical trial, evaluating whether AI-guided mpUS targeted biopsies are non-inferior to MRI-guided biopsies for csPCa detection.
Curious to learn more? Get in touch; we would be glad to connect.
